Abstract
The purpose of this study was to investigate the phenotypic and molecular characterization of a novel plasmid-mediated AmpC-type β-lactamase in Klebsiella pneumoniae E701 isolated from Anhui province in China. In comparison with the ACT-1, sequence analysis revealed that there were 43 point mutations in the coding gene, and 10 of which led to amino-acid substitution. Resistance could be transferred by conjugation or transformation with plasmid DNA into E. coli JM109, which was due to the production of a β-lactamase with an isoelectric point of 8.4 named ACT-6. Cloning, expression, purification and kinetics were carried out to study the characterization of the novel AmpC-type β-lactamase. The results of MIC determinations and substrate profiles showed there was no significant difference in the activities of the novel enzyme and ACT-1. Moreover, the class 1 integron and the whole open reading frame of the novel AmpC-type β-lactamase from K.pneumoniae E701 were detectable in the same size plasmid. This is the first report on the emergence of the novel ACT-6 type β-lactamases in K. pneumoniae.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Ambler, R. P. The structure of β-lactamases. Philos. Trans. R. Soc. Lond. B Biol. Sci. 289, 321–331 (1980).
Bush, K. & Jacoby, G. A. Updated functional classification of β-lactamases. Antimicrob. Agents Chemother. 54, 969–976 (2010).
Sanders, C. C. Chromosomal cephalosporinases responsible for multiple resistances to newer β-lactam antibiotics. Annu. Rev. Microbiol. 41, 573–593 (1987).
Jacoby, G. A. Genetics of extended-spectrum beta-lactamases. Eur. J. Clin. Microbiol. Infect. Dis. 13, 2–11 (1994).
Papanicolaou, G. A., Medeiros, A. A. & Jacoby, G. A. Novel plasmid-mediate β-lactamase (MIR-1) conferring resistance to oxyimino- and α-methoxy β-lactams in clinical isolates of Klebsiella pneumoniae. Antimicrob. Agents Chemother. 34, 2200–2209 (1990).
Jacoby, G. A., Mills, D. M. & Chow, N. Role of β-lactamases and porins in resistance to Ertapenem and other β-lactams in Klebsiella pneumoniae. Antimicrob. Agents Chemother. 48, 3203–3206 (2004).
Philippon, A., Arlet, G. & Jacoby, G. A. Plasmid-determined AmpC-type β-lactamases. Antimicrob. Agents Chemother. 46, 1–11 (2002).
Baker, G. C., Smith, J. J. & Cowan, D. A. Review and re-analysis of domain-specific 16S primers. J. Microbiol Methods. 55, 541–555 (2003).
Clinical and Laboratory Standards Institute. NCCLS performance standards for antimicrobial susceptibility testing; Eighteenth informational supplement. CLSI/NCCLS document M100-S18 28, 1–188 (2008).
Alvarez, M., Tran, J. H., Chow, N. & Jacoby, G. A. Epidemiology of conjugative plasmid-mediated AmpC β-lactamases in the United States. Antimicrob. Agents Chemother. 48, 533–537 (2004).
Skurnik, D. et al. Integron-associated antibiotic resistance and phylogenetic grouping of Escherichia coli isolates from healthy subjects free of recent antibiotic exposure. Antimicrob. Agents Chemother. 49, 3062–3065 (2005).
Kado, C. I. & Liu, S. T. Rapid procedure for detection and isolation of large and small plasmids. J. Bacteriol. 145, 1365–1373 (1981).
Pagani, L. et al. Emerging extended-spectrum β-lactamases in Proteus mirabilis. J. Clin. Microbiol. 40, 1549–1552 (2002).
Zhu, W. M. & Qian, Y. S. Study of kinetics of TEM type β-lactamases. Chin. J. Antibiot. 26, 460–463 (2001).
Bauvois, C. et al. Kinetic properties of four plasmid-mediated AmpC β-lactamases. Antimicrob. Agents Chemother. 49, 4240–4246 (2005).
Rasmussen, B. A. et al. Genetically diverse ceftazidime-resistant isolates from a single center: biochemical and genetic characterization of TEM-10 β-lactamases encoded by different nucleotide sequences. Antimicrob. Agents Chemother. 37, 1989–1992 (1993).
Meziane-Cherif, D., Lambert, T., Dupechez, M., Courvalin, P. & Galimand, M. Genetic and biochemical characterization of OXA-63, a new class D β-lactamase from Brachyspira pilosicoli BM4442. Antimicrob. Agents Chemother. 52, 1264–1268 (2008).
Doi, Y. et al. Inhibitor-sensitive AmpC β-lactamase variant produced by an Escherichia coli clinical isolate resistant to oxyiminocephalosporins and cephamycins. Antimicrob. Agents Chemother. 48, 2652–2658 (2004).
Bradford, P. A. et al. Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC β-lactamase, and the loss of an outer membrane protein. Antimicrob. Agents Chemother. 41, 563–569 (1997).
Chen, Y. et al. ACT-3, a novel plasmid-encoded class C β-lactamase in a Klebsiella pneumoniae isolate from China. J. Antimicrob. Agents. 33, 95–96 (2009).
Dubus, A., Normarck, S., Kania, M. & Page, M. G. P. The role of tyrosine 150 in catalysis of β-lactam hydrolysis by AmpC β-lactamase from Escherichia coli investigated by site-directed mutagenesis. Biochemistry 33, 8577–8586 (1994).
Bauernfeind, A., Stemplinger, I., Jungwirth, R., Wilhelm, R. & Chong, Y. Comparative characterization of the Cephamycinase blaCMY-1 gene and its relationship with other β-lactamase genes. Antimicrob. Agents Chemother. 40, 1926–1930 (1996).
Bauernfeind, A., Wagner, S., Jungwirth, R., Schneider, I. & Meyer, D. A novel class C β-lactamase (FOX-2) in Escherichia coli conferring resistance to cephamycins. Antimicrob. Agents Chemother. 41, 2041–2046 (1997).
Stapleton, P. D., Shannon, K. P. & French, G. L. Carbapenem resistance in Escherichia coli associated with plasmid-determined CMY-4 β-lactamase production and loss of an outer membrane protein. Antimicrob. Agents Chemother. 43, 1206–1210 (1999).
Hall, R. M. & Collis, C. M. Antibiotic resistance in gram-negative bacteria: the role of gene cassettes and integrons. Drug Resist. Updat. 1, 109–119 (1998).
Verdet, C., Arlet, G., Barnaud, G., Lagrange, P. H. & Philippon, A. A novel integron in Salmonella enterica Serovar Enteritidis, carrying the blaDHA-1 gene and its regulator gene ampR, originated from Morganella morganii. Antimicrob. Agents Chemother. 44, 222–225 (2000).
Wachino, J. I. et al. Horizontal transfer of blaCMY-bearing plasmids among clinical Escherichia coli and Klebsiella pneumoniae isolates and emergence of cefepime-hydrolyzing CMY-19. Antimicrob. Agents Chemother. 50, 534–541 (2006).
Bauernfeind, A., Schneider, I., Jungwirth, R., Sahly, H. & Ullmann, U. A novel type of AmpC β-lactamase, ACC-1, produced by a Klebsiella pneumoniae strain causing nosocomial pneumonia. Antimicrob. Agents Chemother. 43, 1924–1931 (1999).
Jenks, P. J., Hu, Y. M., Danel, F., Mehtar, S. & Livermore, D. M. Plasmid-mediated production of class 1(AmpC) β-lactamase by two Klebsiella pneumoniae isolates from the UK. J. Antimicrob. Chemother. 35, 235–236 (1995).
M’Zali, F. H. et al. Transcontinental importation into the UK of Escherichia coli expressing a plasmid-mediated AmpC-type β-lactamase exposed during an outbreak of SHV-5 extended-spectrum β-lactamase in a Leeds hospital. J. Antimicrob Chemother. 40, 823–831 (1997).
Nadjar, D. et al. Outbreak of Klebsiella pneumoniae producing transferable AmpC-type β-lactamase (ACC-1) originating from Hafnia alvei. FEMS Microbiol Lett. 187, 35–40 (2000).
Ploy, M. C. Integron-associated antibiotic resistance in Salmonella enterica Serovar Typhi from Asia. Antimicrob. Agents Chemother. 47, 1427–1429 (2003).
Acknowledgements
This work was supported by the National Natural Science Foundation of China (no 30772286) and Anhui Natural Science Foundation (no 070413110).
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Zhu, Yl., Zhang, Xn., Gao, F. et al. ACT-6, a novel plasmid-encoded class C β-lactamase in a Klebsiella pneumoniae isolate from China. J Antibiot 64, 317–320 (2011). https://doi.org/10.1038/ja.2011.1
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/ja.2011.1
